Menopausal estrogen use and risk of breast cancer

L. A. Brinton, R. N. Hoover, Moyses Szklo, J. F. Fraumeni

Research output: Contribution to journalArticle

Abstract

To assess the relationship of menopausal estrogens to breast cancer risk, the authors conducted a case-control study among 881 cases and 863 controls identified through the Breast Cancer Detection Demonstration Project (BCDDP). Use of estrogens was associated with a relative risk (RR) of 1.24 (95% C.I. 1.0-1.5), with higher risks observed among users of high-dose preparations. Hormone effects predominated among women who received them following bilateral oophorectomy (RR = 1.54), obliterating the protective effect normally associated with the operation. In this group, risk increased with years of estrogen use, reaching risks of 2-3 for users of ten or more years. High risks were also observed among oophorectomized women who used hormones in the presence of other risk factors, including nulliparity, family history of breast cancer, and benign breast disease. These results suggest a possible, although complex, relationship between estrogen use and risk of breast cancer.

Original languageEnglish (US)
Pages (from-to)2517-2522
Number of pages6
JournalCancer
Volume47
Issue number10
StatePublished - 1981

Fingerprint

Estrogens
Breast Neoplasms
Hormones
Breast Diseases
Ovariectomy
Parity
Case-Control Studies

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Brinton, L. A., Hoover, R. N., Szklo, M., & Fraumeni, J. F. (1981). Menopausal estrogen use and risk of breast cancer. Cancer, 47(10), 2517-2522.

Menopausal estrogen use and risk of breast cancer. / Brinton, L. A.; Hoover, R. N.; Szklo, Moyses; Fraumeni, J. F.

In: Cancer, Vol. 47, No. 10, 1981, p. 2517-2522.

Research output: Contribution to journalArticle

Brinton, LA, Hoover, RN, Szklo, M & Fraumeni, JF 1981, 'Menopausal estrogen use and risk of breast cancer', Cancer, vol. 47, no. 10, pp. 2517-2522.
Brinton LA, Hoover RN, Szklo M, Fraumeni JF. Menopausal estrogen use and risk of breast cancer. Cancer. 1981;47(10):2517-2522.
Brinton, L. A. ; Hoover, R. N. ; Szklo, Moyses ; Fraumeni, J. F. / Menopausal estrogen use and risk of breast cancer. In: Cancer. 1981 ; Vol. 47, No. 10. pp. 2517-2522.
@article{06e3c349a0744906a889bf0b4e729b5d,
title = "Menopausal estrogen use and risk of breast cancer",
abstract = "To assess the relationship of menopausal estrogens to breast cancer risk, the authors conducted a case-control study among 881 cases and 863 controls identified through the Breast Cancer Detection Demonstration Project (BCDDP). Use of estrogens was associated with a relative risk (RR) of 1.24 (95{\%} C.I. 1.0-1.5), with higher risks observed among users of high-dose preparations. Hormone effects predominated among women who received them following bilateral oophorectomy (RR = 1.54), obliterating the protective effect normally associated with the operation. In this group, risk increased with years of estrogen use, reaching risks of 2-3 for users of ten or more years. High risks were also observed among oophorectomized women who used hormones in the presence of other risk factors, including nulliparity, family history of breast cancer, and benign breast disease. These results suggest a possible, although complex, relationship between estrogen use and risk of breast cancer.",
author = "Brinton, {L. A.} and Hoover, {R. N.} and Moyses Szklo and Fraumeni, {J. F.}",
year = "1981",
language = "English (US)",
volume = "47",
pages = "2517--2522",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Menopausal estrogen use and risk of breast cancer

AU - Brinton, L. A.

AU - Hoover, R. N.

AU - Szklo, Moyses

AU - Fraumeni, J. F.

PY - 1981

Y1 - 1981

N2 - To assess the relationship of menopausal estrogens to breast cancer risk, the authors conducted a case-control study among 881 cases and 863 controls identified through the Breast Cancer Detection Demonstration Project (BCDDP). Use of estrogens was associated with a relative risk (RR) of 1.24 (95% C.I. 1.0-1.5), with higher risks observed among users of high-dose preparations. Hormone effects predominated among women who received them following bilateral oophorectomy (RR = 1.54), obliterating the protective effect normally associated with the operation. In this group, risk increased with years of estrogen use, reaching risks of 2-3 for users of ten or more years. High risks were also observed among oophorectomized women who used hormones in the presence of other risk factors, including nulliparity, family history of breast cancer, and benign breast disease. These results suggest a possible, although complex, relationship between estrogen use and risk of breast cancer.

AB - To assess the relationship of menopausal estrogens to breast cancer risk, the authors conducted a case-control study among 881 cases and 863 controls identified through the Breast Cancer Detection Demonstration Project (BCDDP). Use of estrogens was associated with a relative risk (RR) of 1.24 (95% C.I. 1.0-1.5), with higher risks observed among users of high-dose preparations. Hormone effects predominated among women who received them following bilateral oophorectomy (RR = 1.54), obliterating the protective effect normally associated with the operation. In this group, risk increased with years of estrogen use, reaching risks of 2-3 for users of ten or more years. High risks were also observed among oophorectomized women who used hormones in the presence of other risk factors, including nulliparity, family history of breast cancer, and benign breast disease. These results suggest a possible, although complex, relationship between estrogen use and risk of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0019457978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019457978&partnerID=8YFLogxK

M3 - Article

C2 - 6268273

AN - SCOPUS:0019457978

VL - 47

SP - 2517

EP - 2522

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 10

ER -